Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial tissue outside the uterus, is responsible for approximately 15% of infertility cases. This condition can result in the formation of ovarian cysts, pelvic adhesions, and blockage of the fallopian tubes. Other conditions, such as pelvic inflammatory disease (PID), can also cause tubal or uterine obstructions, preventing sperm from reaching the egg or a fertilized egg from entering the uterus.
Hormonal imbalances, such as hyperprolactinemia (elevated prolactin levels), can inhibit ovulation. Lifestyle changes can be beneficial in improving fertility and complementing therapeutic interventions. Hormone therapy effectively restores optimal ovarian function in cases of ovulatory or hormonal disorders, while corrective surgery addresses structural abnormalities or blockages.
When other methods prove ineffective, techniques like intrauterine insemination (IUI) and in-vitro fertilization (IVF) are widely used to assist individuals experiencing infertility.
Female infertility is the inability to conceive after at least a year of regular unprotected intercourse, with a global prevalence of around 10%.
Most female infertility cases are due to ovulatory disorders, which hinder oocyte release.
These are broadly categorized as hypothalamic amenorrhea, polycystic ovary syndrome, premature ovarian failure, and hyperprolactinemic anovulation disorders.
About 15% of infertility cases are caused by endometriosis, a condition where there is extra-uterine growth of the endometrial tissue.
Tubal or uterine blockage can also result from other conditions like pelvic inflammatory disease, which can prevent the meeting of sperm and egg or uterine entry of the fertilized egg.
Hormonal imbalances like hyperprolactinemia, characterized by high prolactin levels, inhibit ovulation.
Lifestyle changes can improve fertility and assist therapeutic interventions.
Hormone therapy to restore optimal ovarian function is effective for ovulatory or hormonal disorders, while corrective surgery can address structural abnormalities or blockages.
When other methods fail, techniques such as intrauterine insemination and in-vitro fertilization are widely used to assist with conception.
繁體中文
